Skip to content

Marvel Biosciences Corp Price, Chart & Factor Analysis

Free Data & Analytics Access
Marvel Biosciences Corp · E.MRVL.V · Canada
Use symbol E.MRVL.V in our API & Excel add-in to retrieve this data ↓
0.12
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -100%
Trend -100%
Bubble Risk LOW
Realised Volatility (20D) 73.68%

Marvel Biosciences Corp Forecast

Marvel Biosciences Corp short-term momentum is strongly negative (up over 0 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (0 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 73.7% a year, a typical one-standard-deviation range is 0.1031–0.1269 over a week, 0.0905–0.1395 over a month and 0.0303–0.1997 over a year. (Signals as of 22 Nov 2026.)

Marvel Biosciences Corp Price Chart

MacroFinance.ai

Marvel Biosciences Corp Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Marvel Biosciences Corp
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Marvel Biosciences Corp
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Marvel Biosciences Corp
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Marvel Biosciences Corp, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Marvel Biosciences Corp

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Statistical Distribution of Returns

Plus

How Marvel Biosciences Corp’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Marvel Biosciences Corp behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Marvel Biosciences Corp (Canada)

Marvel Biosciences Corp is a listed security in Canada. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Marvel Biosciences Corp

Frequently asked questions

What is Marvel Biosciences Corp?
Marvel Biosciences Corp is a listed security in Canada. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns and free historical data.
What is the latest Marvel Biosciences Corp price?
The latest close is 0.115 (22 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Marvel Biosciences Corp in an uptrend?
As of 22 Nov 2026, short-term momentum is strongly negative (0 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (0 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Marvel Biosciences Corp?
20-day realised volatility is 73.7% a year (22 Nov 2026), which implies a typical one-standard-deviation move of about 21.3% over a month and 10.4% over a week.
What factors affect Marvel Biosciences Corp?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Marvel Biosciences Corp, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
How are Marvel Biosciences Corp returns analysed?
The Statistical Distribution of Returns section shows the distribution of Marvel Biosciences Corp daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Marvel Biosciences Corp historical data?
In the Free historical data section of this page: the last 10 years of Marvel Biosciences Corp daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Marvel Biosciences Corp historical data (last 10 years)

Browse or instantly download the last 10 years of Marvel Biosciences Corp daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.MRVL.V&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-200.115
2026-11-190.115
2026-11-180.115
2026-11-170.13
2026-11-160.13
2026-11-130.13
2026-11-120.125
2026-11-110.115
2026-11-100.12
2026-11-090.12
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.